Ningfeng Fiona Li

1.5k total citations
11 papers, 1.2k citations indexed

About

Ningfeng Fiona Li is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ningfeng Fiona Li has authored 11 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Ningfeng Fiona Li's work include Cancer Research and Treatments (2 papers), Immune cells in cancer (2 papers) and RNA Interference and Gene Delivery (2 papers). Ningfeng Fiona Li is often cited by papers focused on Cancer Research and Treatments (2 papers), Immune cells in cancer (2 papers) and RNA Interference and Gene Delivery (2 papers). Ningfeng Fiona Li collaborates with scholars based in United Kingdom, United States and Slovakia. Ningfeng Fiona Li's co-authors include Frances R. Balkwill, Kellie A. Charles, Thorsten Hagemann, Hagen Kulbe, Julia L. Wilson, Annette Plüddemann, David A. Leinster, Siamon Gordon, Claudia R. Binder and Florian Klemm and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Ningfeng Fiona Li

11 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ningfeng Fiona Li United Kingdom 11 587 505 457 216 105 11 1.2k
Hong Zheng China 13 505 0.9× 569 1.1× 632 1.4× 179 0.8× 69 0.7× 67 1.4k
Denarda Dangaj Laniti Switzerland 15 544 0.9× 703 1.4× 367 0.8× 186 0.9× 100 1.0× 31 1.1k
Mark G. Cadungog United States 12 524 0.9× 629 1.2× 540 1.2× 148 0.7× 97 0.9× 17 1.3k
Ivraym B. Barsoum Canada 12 537 0.9× 548 1.1× 525 1.1× 452 2.1× 191 1.8× 15 1.4k
Matthieu Le Gallo France 14 309 0.5× 290 0.6× 490 1.1× 219 1.0× 80 0.8× 23 1.0k
Jan Žaloudík Czechia 20 479 0.8× 523 1.0× 582 1.3× 205 0.9× 141 1.3× 62 1.2k
Jin-Yuh Shew Taiwan 12 170 0.3× 470 0.9× 533 1.2× 222 1.0× 157 1.5× 13 1.0k
Michele Cummings United Kingdom 18 198 0.3× 290 0.6× 384 0.8× 171 0.8× 148 1.4× 36 933
Gaynor J. Bates United Kingdom 10 1.1k 1.9× 1.2k 2.3× 634 1.4× 293 1.4× 240 2.3× 12 2.0k
Yasushi Saga Japan 22 200 0.3× 354 0.7× 670 1.5× 251 1.2× 137 1.3× 66 1.4k

Countries citing papers authored by Ningfeng Fiona Li

Since Specialization
Citations

This map shows the geographic impact of Ningfeng Fiona Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ningfeng Fiona Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ningfeng Fiona Li more than expected).

Fields of papers citing papers by Ningfeng Fiona Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ningfeng Fiona Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ningfeng Fiona Li. The network helps show where Ningfeng Fiona Li may publish in the future.

Co-authorship network of co-authors of Ningfeng Fiona Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ningfeng Fiona Li. A scholar is included among the top collaborators of Ningfeng Fiona Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ningfeng Fiona Li. Ningfeng Fiona Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Li, Ningfeng Fiona, Emilios Gemenetzidis, Derek Davies, et al.. (2013). RhoC Interacts with Integrin α5β1 and Enhances Its Trafficking in Migrating Pancreatic Carcinoma Cells. PLoS ONE. 8(12). e81575–e81575. 19 indexed citations
2.
Noël, Elodie, Marc Yeste‐Velasco, Xueying Mao, et al.. (2010). The Association of CCND1 Overexpression and Cisplatin Resistance in Testicular Germ Cell Tumors and Other Cancers. American Journal Of Pathology. 176(6). 2607–2615. 86 indexed citations
3.
Li, Ningfeng Fiona, et al.. (2008). A novel function of colony-stimulating factor 1 receptor in hTERT immortalization of human epithelial cells. Oncogene. 28(5). 773–780. 31 indexed citations
4.
Kocher, Hemant M., J Sandle, Talat Mirza, Ningfeng Fiona Li, & Ian R. Hart. (2008). Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells. Gut. 58(2). 271–284. 49 indexed citations
5.
Li, Ningfeng Fiona, Simon Broad, Yong‐Jie Lu, et al.. (2007). Human ovarian surface epithelial cells immortalized with hTERT maintain functional pRb and p53 expression. Cell Proliferation. 40(5). 780–794. 31 indexed citations
6.
Harrison, Michelle, Nick Maisey, Susan Hoare, et al.. (2007). Tumor Necrosis Factor α As a New Target for Renal Cell Carcinoma: Two Sequential Phase II Trials of Infliximab at Standard and High Dose. Journal of Clinical Oncology. 25(29). 4542–4549. 195 indexed citations
7.
Hagemann, Thorsten, Julia L. Wilson, Frances Burke, et al.. (2006). Ovarian Cancer Cells Polarize Macrophages Toward A Tumor-Associated Phenotype. The Journal of Immunology. 176(8). 5023–5032. 318 indexed citations
8.
9.
Hagemann, Thorsten, Julia L. Wilson, Hagen Kulbe, et al.. (2005). Macrophages Induce Invasiveness of Epithelial Cancer Cells Via NF-κB and JNK. The Journal of Immunology. 175(2). 1197–1205. 348 indexed citations
10.
Li, Ningfeng Fiona, George D. Wilbanks, Frances R. Balkwill, et al.. (2004). A modified medium that significantly improves the growth of human normal ovarian surface epithelial (OSE) cells in vitro. Laboratory Investigation. 84(7). 923–931. 24 indexed citations
11.
Li, Ningfeng Fiona, et al.. (2001). A cost-utility analysis comparing second-line chemotherapy schemes in patients with metastatic breast cancer. Anti-Cancer Drugs. 12(6). 533–540. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Zheng Breakdown of academic impact, for papers by Denarda Dangaj Laniti Breakdown of academic impact, for papers by Mark G. Cadungog Breakdown of academic impact, for papers by Ivraym B. Barsoum Breakdown of academic impact, for papers by Matthieu Le Gallo Breakdown of academic impact, for papers by Jan Žaloudík Breakdown of academic impact, for papers by Jin-Yuh Shew Breakdown of academic impact, for papers by Michele Cummings Breakdown of academic impact, for papers by Gaynor J. Bates Breakdown of academic impact, for papers by Yasushi Saga
Rankless by CCL
2026